Version 1.0 www.crownbio.com | Additional Resources Additional Read supporting white publications, and more. presentations, watch papers, crownbio.com/resources RA Clinical desin trial Statistical to odels [email protected] [email protected] haracolo stud to assess and confir oA assess and confir | interret haracolo data interret SCR AA SCR othesis ree ioarer discoer ioarer ree othesis +1.855.827.6968

treatment treatment models as Schedule ScientificConsultation discuss to Request a consultation project. your [email protected] in vitro and l’ drugs. l’ in vivo, ex vivo, in vivo, Contact Sales US: +1.855.827.6968 UK: +44 (0)870 166 6234 [email protected] Expert high complexity design, assist with experimental to in-house team interpretation. and result analyses, pharmacological data including mouse clinical trials. data pharmacological solutions using in-house and public datasets Proprietary bioinformatics of and . analysis enabling systematic understand drug MoA. covering decades of research collected over datasets Extensive curves, and data, sequencing including growth thousands of models, reliable, clinically relevant test systems for functional for and efficacy systems test relevant clinically reliable, evaluation. to assays genomic and proteomic menu of validated Comprehensive Portfolio of well-characterized Portfolio Rescue ‘unsuccessfu previously stratification. patient Improve Evaluate the predictive value of potential . of potential value the predictive Evaluate to corresponding signatures genomic and proteomic Identify response. Corroborate clinical-preclinical data. clinical-preclinical Corroborate

• • • • • • • • • • encompassing: encompassing: Discover and validate biomarkers through our integrated platform platform integrated our biomarkers through and validate Discover drug development programs. CrownBio’s comprehensive Discovery comprehensive CrownBio’s programs. drug development to: enables you Maximize your clinical success rate by incorporating biomarkers into your your biomarkers into incorporating by rate clinical success your Maximize drug development. drug development. identifying robust and sensitive biomarkers early in and sensitive robust identifying Discovery. De-risk by development therapeutic Discovery. data-informed trial decisions through Biomarker trial decisions through data-informed Gain in-depth and make insights biological

Increase your success rate by bridging discovery knowledge to clinical results knowledge to discovery bridging by rate success your Increase Biomarker Discovery Biomarker